SAN FRANCISCO: The Canterbury Geriatric Medical Research Trust (CGMRT) is one of six Australasian sites tackling early memory loss by trialling a new investigational medication that could help slow the progression of the disease.
Specialist Physician, Dr Nigel Gilchrist, who runs CGMRT is excited about the prospect of the new medication.
“Currently available medications work at managing the symptoms of memory loss but do not necessarily slow the course of the disease. The medication we are trialling potentially does this. If it works, it would be an exciting breakthrough.”